Page results
-
The department specialises in the assessment and management of complex neuropsychiatric conditions occurring in the context of neurological disease.
-
Skeletal uscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
The Pathogen Genomic Unit offers access to explore the clinical applications and interpretation of pathogen genomic data for patients with a variety of infections.
-
This information has been written to prepare you for your hospital stay.
-
The lung function unit is an integral part of the department of Thoracic Medicine, offering a wide range of physiological tests to both inpatients and clinic outpatients within the Trust, to help not only in the diagnoses of lung disorders, but also to assess the severity of these conditions.
-
The department of Thoracic Medicine at UCH has particular expertise in the management of patients with bronchiectasis and respiratory infections (including fungal disease, lung abscess and opportunistic infections).
-
This page provides information for patients visiting the Inflammatory Bowel Disease clinic.
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
-
This information outlines the things that you need to take home after your robotic prostatectomy.
-
OPAT (Outpatient Parenteral Antimicrobial Therapy) is a safe and convenient way to receive intravenous (IV) antibiotic therapy at home or in a clinic.
File results
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy